Presentation is loading. Please wait.

Presentation is loading. Please wait.

The Use of N-of-1 Trials to Individualize Treatment in Patients With Renal Magnesium Wasting  Anneke P. Bech, MD, Jack F.M. Wetzels, MD, Hans Groenewoud,

Similar presentations


Presentation on theme: "The Use of N-of-1 Trials to Individualize Treatment in Patients With Renal Magnesium Wasting  Anneke P. Bech, MD, Jack F.M. Wetzels, MD, Hans Groenewoud,"— Presentation transcript:

1 The Use of N-of-1 Trials to Individualize Treatment in Patients With Renal Magnesium Wasting 
Anneke P. Bech, MD, Jack F.M. Wetzels, MD, Hans Groenewoud, PhD, Tom Nijenhuis, MD, PhD  American Journal of Kidney Diseases  Volume 73, Issue 2, Pages (February 2019) DOI: /j.ajkd Copyright © 2018 National Kidney Foundation, Inc. Terms and Conditions

2 Figure 1 Probability density plots of muscle pain scores of patient 1, by magnesium salt. The peak of the density curve indicates the most probable mean score. For example, the most probable mean scores for muscle pain are 5.95, 6.61, and 6.71 for magnesium aspartate, lactate, and gluconate, respectively. American Journal of Kidney Diseases  , DOI: ( /j.ajkd ) Copyright © 2018 National Kidney Foundation, Inc. Terms and Conditions


Download ppt "The Use of N-of-1 Trials to Individualize Treatment in Patients With Renal Magnesium Wasting  Anneke P. Bech, MD, Jack F.M. Wetzels, MD, Hans Groenewoud,"

Similar presentations


Ads by Google